|
AU2015219120A1
|
|
Methods and systems for rapid detection of microorganisms using free antibodies
|
|
EP2981828A1
|
|
Systems and methods for facilitating diagnosis, prognosis and treatment of cancer based on detection of her3 activation
|
|
US2014274935A1
|
|
Methods for determining viral sensitivity to viral inhibitors
|
|
CA2900393A1
|
|
Methods for indirect determination of reference intervals
|
|
US2014212981A1
|
|
Methods and systems for determining the amount of thiopurine metabolites in a sample
|
|
WO2013163348A1
|
|
Methods and systems for identification of a protein binding site
|
|
US2013197943A1
|
|
Systems, Methods, and Media for Laboratory Benefit Services
|
|
EP2823068A2
|
|
Methods and compositions for determining virus susceptibility to non-nucleoside reverse transcriptase inhibitors
|
|
CN104245961A
|
|
Methods and systems for detection of microorganisms
|
|
WO2013142003A1
|
|
Biologic machines for the detection of biomolecules
|
|
CA2806382A1
|
|
Diagnostic methods and markers for bacterial vaginosis
|
|
CN104039984A
|
|
Methods for the phenotypic detection of HCV inhibitor resistant subpopulations
|
|
WO2013052530A1
|
|
Automated fluid refill system and uses thereof
|
|
WO2012129312A2
|
|
Methods and systems for multiple control validation
|
|
EP2678453A1
|
|
Methods and compositions for determining virus susceptibility to integrase inhibitors
|
|
SG192661A1
|
|
Methods and systems for determining the presence or amount of testosterone in a sample
|
|
CA2766675A1
|
|
Methods and systems for multiplex analysis of biomolecules by liquid chromatography-mass spectrometry
|
|
US2010291594A1
|
|
ErbB Surface Receptor Complexes as Biomarkers
|
|
EP2387717A1
|
|
Methods of determining patient response by measurement of her-2 expression
|
|
WO2010017190A1
|
|
Clinical laboratory-based disease management program, with automated patient-specific treatment advice
|
